US Stock MarketDetailed Quotes
NAMSW NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM)
- 9.400
- -0.210-2.19%
Close Apr 19 16:00 ET
0Market Cap0.00P/E (TTM)
9.400High9.000Low640Volume9.000Open9.610Pre Close5.80KTurnover0.00%Turnover Ratio0.00P/E (Static)0Shares14.67052wk High0.00P/B0Float Cap0.99052wk Low--Dividend TTM0Shs Float14.670Historical High--Div YieldTTM4.16%Amplitude0.464Historical Low9.065Avg Price1Lot Size
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|
| Total revenue | -86.28%14.09M | 102.69M | 0 | 0 |
| Operating revenue | -86.28%14.09M | --102.69M | --0 | --0 |
| Cost of revenue | ||||
| Gross profit | ||||
| Operating expense | 87.77%189.2M | 190.78%100.76M | 433.78%34.65M | 6.49M |
| Selling and administrative expenses | 112.42%29.77M | 146.87%14.02M | 274.65%5.68M | --1.52M |
| -Selling and marketing expense | 9.80%4.34M | 304.30%3.95M | 7,121.27%977K | --13.53K |
| -General and administrative expense | 152.70%25.43M | 114.15%10.07M | 212.96%4.7M | --1.5M |
| Research and development costs | 83.79%159.42M | 199.39%86.74M | 482.37%28.97M | --4.98M |
| Depreciation amortization depletion | ---- | ---- | ---- | --1.23K |
| -Depreciation and amortization | ---- | ---- | ---- | --1.23K |
| Operating profit | -9,149.35%-175.11M | 105.58%1.94M | -433.78%-34.65M | -6.49M |
| Net non-operating interest income expense | 159.20%3.42M | -684.12%-5.78M | -21.05%-737K | -608.83K |
| Non-operating interest income | --11.28M | --0 | --0 | --0 |
| Non-operating interest expense | --0 | -30.17%287K | -2.86%411K | --423.1K |
| Total other finance cost | 43.15%7.86M | 1,584.66%5.49M | 75.53%326K | --185.72K |
| Other net income (expense) | 72.19%-5.23M | -193.73%-18.79M | -21,770.90%-6.4M | 29.52K |
| Gain on sale of security | 51.56%-5.23M | -732.36%-10.79M | 5,679.36%1.71M | --29.52K |
| Special income (charges) | --0 | --0 | ---883K | --0 |
| -Less：Restructuring and merger&acquisition | ---- | ---- | ---- | --0 |
| -Less:Other special charges | ---- | ---- | --883K | ---- |
| Other non- operating income (expenses) | ---- | -10.83%-8M | ---7.22M | ---- |
| Income before tax | -681.61%-176.91M | 45.83%-22.63M | -490.94%-41.79M | -7.07M |
| Income tax | 27K | 0 | 0 | 0 |
| Net income | -681.73%-176.94M | 45.83%-22.63M | -490.94%-41.79M | -7.07M |
| Net income continuous Operations | -681.73%-176.94M | 45.83%-22.63M | -490.94%-41.79M | ---7.07M |
| Minority interest income | ||||
| Net income attributable to the parent company | -681.73%-176.94M | 45.83%-22.63M | -490.94%-41.79M | -7.07M |
| Preferred stock dividends | ||||
| Other preferred stock dividends | ||||
| Net income attributable to common stockholders | -681.73%-176.94M | 45.83%-22.63M | -490.94%-41.79M | -7.07M |
| Basic earnings per share | ||||
| Diluted earnings per share | ||||
| Dividend per share | ||||
| Currency Unit | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg